Albert Bourla insider trades: Pfizer (PFE) stock buys and sales
Trades on the price chart
Daily close, with an arrow on each day they bought or sold
Companies
Where Albert reports to the SEC
Open-market buys and sales
3 trades reported on SEC Form 4, newest first
| Date | Stock | Type | Shares | Price | Value | Holding | Reported |
|---|---|---|---|---|---|---|---|
| Aug 12, 2026 | PFE | ↑ Buy | 38,000 | $26.34 | $1.0M | Direct | Aug 12, 2026 (0d) |
| Nov 9, 2020 | PFE | ↓ Sell10b5-1 | 132,508 | $41.94 | $5.6M | Direct | Nov 10, 2020 (1d) |
| Nov 4, 2016 | PFE | ↓ Sell | 18,390 | $30.05 | $553K | Direct | Nov 7, 2016 (3d) |
Each row is one filing's trades in one stock, summed. Shares and prices are as filed, before any later stock split.
Other PFE insiders
Open-market trades in the last 12 months
About Albert Bourla's insider trades
Albert Bourla is Chairman & CEO at Pfizer (PFE). Since Nov 4, 2016, Albert has reported 1 open-market purchase worth $1.0M and 2 sales worth $6.1M on SEC Form 4. In the last 12 months: 1 buy ($1.0M).
1 sale (91% of the value sold) was made under a Rule 10b5-1 trading plan, which is set up months in advance and runs on a schedule, so it says little about how the insider sees the stock today.
Their filings also include grants and awards (324 filings), shares withheld for taxes (25 filings), option exercises (21 filings), other transactions (5 filings). These aren't open-market trades and aren't counted above.
How to read insider trades
Officers, directors and owners of more than 10% of a company must report trades in its stock on SEC Form 4, usually within two business days. Purchases with their own money are the stronger signal: insiders sell for many reasons (taxes, diversification, a house), but buy for one. See every PFE insider trade, the latest insider trades across the market, or cluster buys, when several insiders buy the same stock within days.